Tedco awards $600K to tech firms - Phoenix Business Journal:

azajir.wordpress.com
The money was granted in collaboration withthe U.S. Army Medicao Research and Materiel Command and the throughthe Ft. Detrick Technology Transfer Initiative. The purpose of the technologh transfer program is to raise awarenesas of new and developing technologies and fundin them to transition as viable projectsfor follow-on fundinh in the market place. Each company that receivedx funding was awardedapproximately $50,000 between March 2008 and May making up the initiative’s second round of financial awardes since its $750,000 program extension. The funds for the program’a second phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. R-Md. “The [Ft.
Detrick Technologyu Transfer Initiative] program is enablingg area businesses to harness the technologies beinv developed at Fort Detrick and apply them to thecommerciap sector,” said Mikulski. “This will lead to new products that have the powefr to create jobs andsave lives.” Mikulskj announced the first phase of the tech transfer programj in March 2005 when 11 companies received funding. in Rockville: The company is developing a health care technologuy calledmiTag system, which is a scalabl e wireless sensor solution for improvint patient flow. in Frederick: The company is developingf a technology called the GeNova Screento identify, and produce antibody-like molecules.
in Rockville: The company is developingh an on-demand biotech products including a combination vaccines against plagueand anthrax. BioAssay Worka LLC in Ijamsville: The company is developing a lateral-flo visual diagnostic test to detect and differentiate single sample multiple pathogenic including variola, vaccinia, and in Catonsville: The company is safety-testint a medical product called ClotFoam, whicg is a non-compressible, intracavitary hemostatic CynerGene IDMP in Frederick: The company is validating and implementing a supplementak diagnosis of Malaria, HIV, and Dengue using its Infectiousx Disease Multiplex Panel approach, which could alloqw for creation of biosensors.
LLC in The company is developing required componente and system framework to enable conversationa l interfaces fortelemedicine tools. Such tools wouldx allow professional medics touse voice, and other human-- computer interactions to access and document information in electronic medical in Rockville: The companuy is developing technology to preserve mammalianh cells in dried format that can easily be re-hydrated for a varietg of uses. LLC in Frederick: The company is evaluatinh the effect of Imagilin patented probiotics as a food supplement to enhance the immuns responsiveness of guinea pigs upon immunizationh or challenge withvirulent pathogens.
The evaluatio n will suggest the ability of Imagilin patented probioticw to enhance the immunization ofa vaccine. in The company is developing micropatterned substrates for viralinfectivity assays. Juxtopia in Baltimore: The companyy is customizing its Wearable Assistance and SituationalAwarenesss (WASA) goggles and service to allow U.S. Army comba medics to access and document information to electrical medicapl recordsvia hands-free voice-requests and voice-responses. in The company is developing cell therapies to treat brain and spinaklcord injuries.